Thorlef Spickschen is Director at Clovis Oncology, Inc. (CLVS). They have made 10 open-market trades across 1 company since 2011, most recently 2019-08-16.
CIK 0001268374
3 open-market purchases totalling $272K since 2011, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLVS | 58,176 | $5K |
Shares reported on the most recent Form 4, priced at the 2019-08-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLVS | BUY | 2019-08-16 | 2019-08-16 | $5.67 | $49K | -2.9% | -4.2% | +6.9% |
| CLVS | BUY | 2019-08-14 | 2019-08-15 | $5.46 | $50K | +1.1% | +3.5% | +20.0% |
| CLVS | SELL | 2018-04-09 | 2018-04-09 | $60.02 | $270K | -9.7% | -18.4% | -14.0% |
| CLVS | SELL | 2018-03-08 | 2018-03-09 | $61.47 | $277K | -7.3% | -6.0% | -27.1% |
| CLVS | SELL | 2018-02-22 | 2018-02-23 | $60.00 | $270K | +4.5% | -1.2% | -16.7% |
| CLVS | SELL | 2018-01-08 | 2018-01-09 | $64.97 | $292K | -1.7% | -18.8% | -4.8% |
| CLVS | SELL | 2017-12-08 | 2017-12-08 | $60.00 | $270K | -1.8% | +0.4% | -1.7% |
| CLVS | SELL | 2015-05-13 | 2015-05-15 | $85.00 | $366K | -29.4% | -2.5% | -2.5% |
| CLVS | SELL | 2013-12-04 | 2013-12-06 | $56.10 | $505K | -29.4% | -2.5% | -2.5% |
| CLVS | BUY | 2011-11-21 | 2011-11-21 | $13.00 | $173K | -29.4% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.